SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Àngels García-Cazorla, Rafael Artuch, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, 2015,

    CrossRef

  2. 2
    Katja Lohmann, Christine Klein, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, 2015,

    CrossRef

  3. 3
    Ryan W. Lee, Andrea Poretti, Julie S. Cohen, Eric Levey, Hilary Gwynn, Michael V. Johnston, Alexander H. Hoon, Ali Fatemi, A Diagnostic Approach for Cerebral Palsy in the Genomic Era, NeuroMolecular Medicine, 2014, 16, 4, 821

    CrossRef

  4. You have free access to this content4
    J. Koht, A. Rengmark, T. Opladen, K. A. Bjørnarå, T. Selberg, C. M. E. Tallaksen, N. Blau, M. Toft, Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene, Acta Neurologica Scandinavica, 2014, 129,
  5. 5
    J. Ng, S. J. R. Heales, M. A. Kurian, Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders, Pediatric Drugs, 2014, 16, 4, 275

    CrossRef

  6. 6
    Woong-Woo Lee, Beom Seok Jeon, Clinical Spectrum of Dopa-Responsive Dystonia and Related Disorders, Current Neurology and Neuroscience Reports, 2014, 14, 7

    CrossRef

  7. 7
    Ingo Lange, Dirk Geerts, David J. Feith, Gabor Mocz, Jan Koster, André S. Bachmann, Novel Interaction of Ornithine Decarboxylase with Sepiapterin Reductase Regulates Neuroblastoma Cell Proliferation, Journal of Molecular Biology, 2014, 426, 2, 332

    CrossRef

  8. 8
    Y. Furukawa, S. J. Kish, Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia, Brain, 2014,

    CrossRef

  9. 9
    Krystyna Szymańska, Katarzyna Kuśmierska, Maria Nowacka, Jolanta Sykut-Cegielska, Urszula Demkow, Phenotypic features of children with neurodevelopmental diseases in relation to biogenic amines, Respiratory Physiology & Neurobiology, 2014,

    CrossRef

  10. 10
    Natan Gadoth, Arie Oksenberg, Sleep and Sleep Disorders in Rare Hereditary Diseases: A Reminder for the Pediatrician, Pediatric and Adult Neurologist, General Practitioner, and Sleep Specialist, Frontiers in Neurology, 2014, 5,

    CrossRef

  11. 11
    Mary Ann Thenganatt, Joseph Jankovic, Treatment of Dystonia, Neurotherapeutics, 2014, 11, 1, 139

    CrossRef

  12. 12
    Clara Marecos, Joanne Ng, Manju A. Kurian, What is new for monoamine neurotransmitter disorders?, Journal of Inherited Metabolic Disease, 2014, 37, 4, 619

    CrossRef

  13. 13
    Jutta Gärtner, Christian Körner, Alfried Kohlschütter, Nicole Muschol, Susanne A. Schneider, Ute Spiekerkötter, Robert Steinfeld, Christian Thiel, Ekkehard Wilichowski, Neuropädiatrie, 2014,

    CrossRef

  14. 14
    Bethany K. Wilson, Ellen J. Hess, Animal models for dystonia, Movement Disorders, 2013, 28, 7
  15. 15
    Maria Stamelou, Scarlett C. Lai, Annu Aggarwal, Susanne A. Schneider, Henry Houlden, Tu-Hsueh Yeh, Amit Batla, Chin-Song Lu, Mohit Bhatt, Kailash P. Bhatia, Dystonic opisthotonus: A “red flag” for neurodegeneration with brain iron accumulation syndromes?, Movement Disorders, 2013, 28, 10
  16. 16
    Joseph Jankovic, Medical treatment of dystonia, Movement Disorders, 2013, 28, 7
  17. 17
    Thomas Opladen, Georg F. Hoffmann, Andrea A. Kühn, Nenad Blau, Pitfalls in phenylalanine loading test in the diagnosis of dopa-responsive dystonia, Molecular Genetics and Metabolism, 2013, 108, 3, 195

    CrossRef

  18. 18
    H. Haruki, M. G. Pedersen, K. I. Gorska, F. Pojer, K. Johnsson, Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs, Science, 2013, 340, 6135, 987

    CrossRef

  19. 19
    G. Charlesworth, K. P. Bhatia, N. W. Wood, The genetics of dystonia: new twists in an old tale, Brain, 2013, 136, 7, 2017

    CrossRef

  20. 20
    Thomas Opladen, Georg F. Hoffmann, Nenad Blau, An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia, Journal of Inherited Metabolic Disease, 2012, 35, 6, 963

    CrossRef